Sarah Blagden

Now, a clinical trial is being launched in the UK for a vaccine to protect against a type of lung cancer, which kills tens of thousands of people every year.

Oxford University oncologist Professor Sarah Blagden founded the project, which has led to the trial.

She's been speaking to Sarah Montague.

We know that there are studies ongoing looking at vaccines to treat cancer, and some of these have had really positive results.

We have a project looking at protecting women who carry the BRCA gene mutation from getting ovarian cancer and breast cancer, and we're also looking at a vaccine with a sort of more broad effect against colorectal cancer.

So we have a pipeline of vaccines, and we want to bring in, you know, more cancer types as we go because we're starting to see sort of general principles can be applied across all of the studies that we're designing.

Professor Sarah Blagden.

[instrumental music plays] Still to come in this podcast, is it the end of Ronaldo's international career as he walks out of the Portugal camp?